Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts

Massimo Aureli, Rosaria Bassi, Nicoletta Loberto, Stefano Regis, Alessandro Prinetti, Vanna Chigorno, Johannes M. Aerts, Rolf G. Boot, Mirella Filocamo, Sandro Sonnino

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Gaucher disease (GD) is the most common lysosomal disorder and is caused by an inherited autosomal recessive deficiency in β-glucocerebrosidase. This enzyme, like other glycohydrolases involved in glycosphingolipid (GSL) metabolism, is present in both plasma membrane (PM) and intracellular fractions. We analyzed the activities of CBE-sensitive β-glucosidase (GBA1) and AMP-DNM-sensitive β-glucosidase (GBA2) in total cell lysates and PM of human fibroblast cell lines from control (normal) subjects and from patients with GD clinical types 1, 2, and 3. GBA1 activities in both total lysate and PM of GD fibroblasts were low, and their relative percentages were similar to those of control cells. In contrast, GBA2 activities were higher in GD cells than in control cells, and the degree of increase differed among the three GD types. The increase of GBA2 enzyme activity was correlated with increased expression of GBA2 protein as evaluated by QRT-PCR. Activities of β-galactosidase and β-hexosaminidase in PM were significantly higher for GD cells than for control cells and also showed significant differences among the three GD types, suggesting the occurrence of cross-talk among the enzymes involved in GSL metabolism. Our findings indicate that the profiles of glycohydrolase activities in PM may provide a valuable tool to refine the classification of GD into distinct clinical types.

Original languageEnglish
Pages (from-to)1081-1091
Number of pages11
JournalJournal of Inherited Metabolic Disease
Volume35
Issue number6
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Gaucher Disease
Glycoside Hydrolases
Fibroblasts
Cell Membrane
Glucosidases
Glycosphingolipids
Enzymes
Galactosidases
Hexosaminidases
Cell Line
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts. / Aureli, Massimo; Bassi, Rosaria; Loberto, Nicoletta; Regis, Stefano; Prinetti, Alessandro; Chigorno, Vanna; Aerts, Johannes M.; Boot, Rolf G.; Filocamo, Mirella; Sonnino, Sandro.

In: Journal of Inherited Metabolic Disease, Vol. 35, No. 6, 11.2012, p. 1081-1091.

Research output: Contribution to journalArticle

Aureli, M, Bassi, R, Loberto, N, Regis, S, Prinetti, A, Chigorno, V, Aerts, JM, Boot, RG, Filocamo, M & Sonnino, S 2012, 'Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts', Journal of Inherited Metabolic Disease, vol. 35, no. 6, pp. 1081-1091. https://doi.org/10.1007/s10545-012-9478-x
Aureli, Massimo ; Bassi, Rosaria ; Loberto, Nicoletta ; Regis, Stefano ; Prinetti, Alessandro ; Chigorno, Vanna ; Aerts, Johannes M. ; Boot, Rolf G. ; Filocamo, Mirella ; Sonnino, Sandro. / Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts. In: Journal of Inherited Metabolic Disease. 2012 ; Vol. 35, No. 6. pp. 1081-1091.
@article{1c8d2db721584eb5a2051bdef82987d4,
title = "Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts",
abstract = "Gaucher disease (GD) is the most common lysosomal disorder and is caused by an inherited autosomal recessive deficiency in β-glucocerebrosidase. This enzyme, like other glycohydrolases involved in glycosphingolipid (GSL) metabolism, is present in both plasma membrane (PM) and intracellular fractions. We analyzed the activities of CBE-sensitive β-glucosidase (GBA1) and AMP-DNM-sensitive β-glucosidase (GBA2) in total cell lysates and PM of human fibroblast cell lines from control (normal) subjects and from patients with GD clinical types 1, 2, and 3. GBA1 activities in both total lysate and PM of GD fibroblasts were low, and their relative percentages were similar to those of control cells. In contrast, GBA2 activities were higher in GD cells than in control cells, and the degree of increase differed among the three GD types. The increase of GBA2 enzyme activity was correlated with increased expression of GBA2 protein as evaluated by QRT-PCR. Activities of β-galactosidase and β-hexosaminidase in PM were significantly higher for GD cells than for control cells and also showed significant differences among the three GD types, suggesting the occurrence of cross-talk among the enzymes involved in GSL metabolism. Our findings indicate that the profiles of glycohydrolase activities in PM may provide a valuable tool to refine the classification of GD into distinct clinical types.",
author = "Massimo Aureli and Rosaria Bassi and Nicoletta Loberto and Stefano Regis and Alessandro Prinetti and Vanna Chigorno and Aerts, {Johannes M.} and Boot, {Rolf G.} and Mirella Filocamo and Sandro Sonnino",
year = "2012",
month = "11",
doi = "10.1007/s10545-012-9478-x",
language = "English",
volume = "35",
pages = "1081--1091",
journal = "Journal of Inherited Metabolic Disease",
issn = "0141-8955",
publisher = "Springer Netherlands",
number = "6",

}

TY - JOUR

T1 - Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts

AU - Aureli, Massimo

AU - Bassi, Rosaria

AU - Loberto, Nicoletta

AU - Regis, Stefano

AU - Prinetti, Alessandro

AU - Chigorno, Vanna

AU - Aerts, Johannes M.

AU - Boot, Rolf G.

AU - Filocamo, Mirella

AU - Sonnino, Sandro

PY - 2012/11

Y1 - 2012/11

N2 - Gaucher disease (GD) is the most common lysosomal disorder and is caused by an inherited autosomal recessive deficiency in β-glucocerebrosidase. This enzyme, like other glycohydrolases involved in glycosphingolipid (GSL) metabolism, is present in both plasma membrane (PM) and intracellular fractions. We analyzed the activities of CBE-sensitive β-glucosidase (GBA1) and AMP-DNM-sensitive β-glucosidase (GBA2) in total cell lysates and PM of human fibroblast cell lines from control (normal) subjects and from patients with GD clinical types 1, 2, and 3. GBA1 activities in both total lysate and PM of GD fibroblasts were low, and their relative percentages were similar to those of control cells. In contrast, GBA2 activities were higher in GD cells than in control cells, and the degree of increase differed among the three GD types. The increase of GBA2 enzyme activity was correlated with increased expression of GBA2 protein as evaluated by QRT-PCR. Activities of β-galactosidase and β-hexosaminidase in PM were significantly higher for GD cells than for control cells and also showed significant differences among the three GD types, suggesting the occurrence of cross-talk among the enzymes involved in GSL metabolism. Our findings indicate that the profiles of glycohydrolase activities in PM may provide a valuable tool to refine the classification of GD into distinct clinical types.

AB - Gaucher disease (GD) is the most common lysosomal disorder and is caused by an inherited autosomal recessive deficiency in β-glucocerebrosidase. This enzyme, like other glycohydrolases involved in glycosphingolipid (GSL) metabolism, is present in both plasma membrane (PM) and intracellular fractions. We analyzed the activities of CBE-sensitive β-glucosidase (GBA1) and AMP-DNM-sensitive β-glucosidase (GBA2) in total cell lysates and PM of human fibroblast cell lines from control (normal) subjects and from patients with GD clinical types 1, 2, and 3. GBA1 activities in both total lysate and PM of GD fibroblasts were low, and their relative percentages were similar to those of control cells. In contrast, GBA2 activities were higher in GD cells than in control cells, and the degree of increase differed among the three GD types. The increase of GBA2 enzyme activity was correlated with increased expression of GBA2 protein as evaluated by QRT-PCR. Activities of β-galactosidase and β-hexosaminidase in PM were significantly higher for GD cells than for control cells and also showed significant differences among the three GD types, suggesting the occurrence of cross-talk among the enzymes involved in GSL metabolism. Our findings indicate that the profiles of glycohydrolase activities in PM may provide a valuable tool to refine the classification of GD into distinct clinical types.

UR - http://www.scopus.com/inward/record.url?scp=84867890753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867890753&partnerID=8YFLogxK

U2 - 10.1007/s10545-012-9478-x

DO - 10.1007/s10545-012-9478-x

M3 - Article

C2 - 22526844

AN - SCOPUS:84867890753

VL - 35

SP - 1081

EP - 1091

JO - Journal of Inherited Metabolic Disease

JF - Journal of Inherited Metabolic Disease

SN - 0141-8955

IS - 6

ER -